APPW2025

^○Ari Ogaki¹, Shinichi Kinoshita¹, Yuji Ikegaya¹, Ryuta Koyama^1,2 (1.The University of Tokyo, 2.National Center of Neurology and Psychiatry)

^○Kazuki Fujimori¹, Hidetoshi Saitoh², Kota Tsunoda¹, Youhei Kurino¹, Kaoru Seiriki³, Hitoshi Hashimoto^3,4,5,6,7, Makoto Tsuda¹ (1.Department of Molecular and System Pharmacology, Graduate School of Pharmaceutical Sciences, Kyushu University, 2.Department of Pharmaceutical Sciences, International University of Health and Welfare, Fukuoka, Japan., 3.Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan., 4.Molecular Research Center for Children's Mental Development, United Graduate School of Child Development, Osaka University, Osaka, Japan., 5.Division of Bioscience, Institute for Datability Science, Osaka University, Osaka, Japan., 6.Transdimensional Life Imaging Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University, Osaka, Japan., 7.Department of Molecular Pharmaceutical Sciences, Graduate School of Medicine, Osaka University, Osaka, Japan.)

^○Taichi Onishi¹, Rinako Miyano², Himawari Hirai², Hirokazu Sakamoto¹, Yohei Okubo³, Shigeyuki Namiki¹, Takeshi Sakaba², Kenzo Hirose¹ (1.the University of Tokyo, 2.Doshisha University, 3.Juntendo University)

^○Yuto Kubota^1,2, Eiji Shigetomi^1,2, Kozo Saito^1,2, Youichi Shinozaki^1,2, Kenji Tanaka³, Nobuhiko Ohno^4,5, Schuichi Koizumi^1,2 (1.Univ. of Yamanashi, 2.Yamanashi GLIA center, 3.Keio Univ., 4.Jichi Med. Univ., 5.NIPS)

^○Shota Tobori¹, Kosei Tamada¹, Kyoko Sawada¹, Nagi Uemura¹, Kazuki Nagayasu^1,2, Shuji Kaneko¹, Hisashi Shirakawa¹ (1.Grad. Sch. Pharmaceut. Sci., Kyoto Univ., 2.Grad. Sch. Pharmaceut. Sci., Osaka Univ.)

^○Keisuke Nishikawa¹, Hirohito Esaki¹, Kanta Imai¹, Ibuki Kawasaki², Eito Oowada², Naoya Nishitani^1,2, Satoshi Deyama^1,2, Katsuyuki Kaneda^1,2 (1.Lab. Mol. Pharmacol., Inst. Med., Pharmaceut., Health Sci., Kanazawa Univ., 2.Lab. Mol. Pharmacol., Sch. Pharmaceut. Sci., Kanazawa Univ.)

^○Liming Yang^1,2, Josan Gandawijaya¹, Emily-Rose Martin¹, Kate L J Ellacott¹, Daisuke Yamada², Akiyoshi Saitoh², Asami Oguro-Ando^1,2 (1.University of Exeter, Faculty of Health and Life Sciences, Department of Clinical and Biomedical Sciences, 2.Tokyo University of Science, Faculty of Pharmaceutical Sciences, Department of Pharmacology)

^○Takahiro Ishimoto, Shoma Yamada, Maki Watanabe, Reiya Yamashita, Yusuke Masuo, Yukio Kato (Faculty of Pharmacy, Kanazawa University)

^○Tsugumi Yamauchi¹, Toshinori Yoshioka¹, Daisuke Yamada¹, Satoshi Iriyama², Kazumi Yoshizawa³, Satoru Miyazaki⁴, Akiyoshi Saitoh¹ (1.Lab Pharmacol., Fac Pharm Sci, Tokyo Univ of Science, 2.Lab Quant info dynamics, Fac Sci and Tech, Tokyo Univ of Science, 3.Lab Disease Pharmcol, Fac Pharm Sci, Tokyo Univ of Science, 4.Lab Bioinfo, Fac Pharm Sci, Tokyo Univ of Science)